Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Dezember 2025 19:43 ET | Quelle: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO

RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026
23. September 2025 07:00 ET | Quelle: Transpire Bio

Transpire Bio’s ANDA for Generic Breo® Ellipta® Accepted for Filing By the U.S. FDA

Transpire Bio's abbreviated new drug application for fluticasone furoate and vilanterol inhalation powder has been accepted for filing by the FDA
26. Juni 2023 06:15 ET | Quelle: RetinalGeniX Technologies, Inc.

RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program

PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...
07. Juni 2023 05:35 ET | Quelle: RetinalGeniX Technologies, Inc.

Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS

PETALUMA, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS. Mr. Watson’s...